Crossmark

Attenuated Toxoplasma gondii enhances the antitumor efficacy of anti-PD1 antibody by altering the tumor microenvironment in a pancreatic cancer mouse model

Crossref DOI link: https://doi.org/10.1007/s00432-022-04036-8

Published Online: 2022-05-12

Published Print: 2022-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bahwal, Said Ahmed

Chen, Jane J.

E, Lilin

Hao, Taofang

Chen, Jiancong

Carruthers, Vern B.

Lai, Jiaming

Zhou, Xingwang https://orcid.org/0000-0001-8145-1476
Funding

Funding for this research was provided by:

Guangzhou Science and Technology Project (201803010027)

National Natural Science Foundation of China (82174022)

Guangdong Basic and Applied Basic Research Foundation (2019B1515120051)
License Information

Text and Data Mining valid from 2022-05-12

Version of Record valid from 2022-05-12
More Information

Article History

Received: 2 March 2022

Accepted: 19 April 2022

First Online: 12 May 2022

Declarations

:

: The author(s) declare that they have no conflict of interest.

: All animal protocols were approved by the Institutional Animal Care and Use Committee at Sun Yat-sen University for animal welfare.

Document is current

Any future updates will be listed below